Описание
Antiviral efficacy data for the EAM-ESN blend against influenza A/H1N1 and human betacoronavirus HCoV-OC43 show dose-dependent viral inhibition. The combination appears to exhibit enhanced antiviral activity compared to individual extracts.
Figure 4
ChartSource Paper
Inhibition of Human Respiratory Influenza A Virus and Human Betacoronavirus-1 by the Blend of Double-Standardized Extracts of Aronia melanocarpa (Michx.) …Cite This Figure
![Figure 4: Antiviral efficacy data for the EAM-ESN blend against influenza A/H1N1 and human betacoronavirus HCoV-OC43 show dose-dependent viral inhibition. The combination appears to exhibit enhanced antiviral activity compared to individual extracts.]() > Source: Michał Ochnik et al. "Inhibition of Human Respiratory Influenza A Virus and Human Betacoronavirus-1 by." *Pharmaceuticals (Basel, Switzerland)*, 2022. PMID: [35631445](https://pubmed.ncbi.nlm.nih.gov/35631445/)
<figure> <img src="" alt="Antiviral efficacy data for the EAM-ESN blend against influenza A/H1N1 and human betacoronavirus HCoV-OC43 show dose-dependent viral inhibition. The combination appears to exhibit enhanced antiviral activity compared to individual extracts." /> <figcaption>Figure 4. Antiviral efficacy data for the EAM-ESN blend against influenza A/H1N1 and human betacoronavirus HCoV-OC43 show dose-dependent viral inhibition. The combination appears to exhibit enhanced antiviral activity compared to individual extracts.<br> Source: Michał Ochnik et al. "Inhibition of Human Respiratory Influenza A Virus and Human Betacoronavirus-1 by." <em>Pharmaceuticals (Basel, Switzerland)</em>, 2022. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/35631445/">35631445</a></figcaption> </figure>